A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer
| Autor: | Nicholas Vogelzang, Norman Block, Julie Jones, Roohollah Sharifi, Michael Sarosdy, Peter Venner, A. Lynn Patterson, Mark Soloway, Paul F. Schellhammer, Geert J.C.M. Kolvenbag |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
endocrine system
medicine.medical_specialty Bicalutamide business.industry Urology Goserelin medicine.disease Flutamide Prostate cancer chemistry.chemical_compound Prostate-specific antigen Endocrinology medicine.anatomical_structure chemistry Prostate Internal medicine medicine Luteinizing hormone business hormones hormone substitutes and hormone antagonists medicine.drug Hormone |
| Zdroj: | Urology. 45:745-752 |
| ISSN: | 0090-4295 |
| DOI: | 10.1016/s0090-4295(99)80077-6 |
| Popis: | Objectives To compare the efficacy and safety of bicalutamide and flutamide, each used in combination with luteinizing hormone-releasing hormone analogue (LHRH-A) therapy, in patients with untreated metastatic (Stage D2) prostate cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect